COMMUNIQUÉS West-GlobeNewswire

-
Denali Therapeutics Announces Advancement and Expansion of Its LRRK2 Inhibitor Clinical Program for Parkinson’s Disease
20/12/2017 - 23:50 -
Apellis Finalizes Phase 3 Clinical Trial Plans for Geographic Atrophy Treatment with APL-2
20/12/2017 - 23:30 -
Kraig Biocraft Laboratories posts Holiday Letter to Shareholders
20/12/2017 - 23:30 -
Kalytera Therapeutics, Inc. Announces Closing of Brokered Private Placement
20/12/2017 - 23:13 -
Aeterna Zentaris Announces FDA Approval of Macrilen™ (macimorelin) for Diagnosis of Adult Growth Hormone Deficiency
20/12/2017 - 23:00 -
HMS to Present at the J.P. Morgan 36th Annual Healthcare Conference
20/12/2017 - 22:30 -
The Cooper Companies Sets Annual Meeting and Stockholder Record Dates
20/12/2017 - 22:15 -
Mersana Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
20/12/2017 - 22:01 -
AMAG Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference
20/12/2017 - 22:01 -
Tabula Rasa HealthCare Subsidiary Partners with The Health Plan of San Mateo to deliver Comprehensive Medication Management Services
20/12/2017 - 20:34 -
Helomics® Corporation and Ariel Precision Medicine, Inc. sign a services agreement to Advance Clinical Genomics in Precision Medicine Applications
20/12/2017 - 20:00 -
Procter & Gamble Present Donation to American College of Prosthodontists Education Foundation
20/12/2017 - 18:17 -
CORRECTION - Achillion Pharmaceuticals, Inc.
20/12/2017 - 18:12 -
Adherium Highlights Milestones Achieved in Advance of 2018
20/12/2017 - 18:03 -
Sensorion to Participate in Corporate Access Event in San Francisco, January 8 – 10, 2018
20/12/2017 - 18:00 -
CyberFuels, Inc. Completes Agreement with Hightowers Petroleum Company for Supply Management and Logistic Services for United States and Canada
20/12/2017 - 17:05 -
Tivity Health to Present at the 36th Annual J.P. Morgan Healthcare Conference
20/12/2017 - 17:00 -
Gunnison Valley Health Significantly Improves Revenue Cycle Time with ABILITY | EASE All-Payer
20/12/2017 - 16:00 -
Data Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors
20/12/2017 - 16:00
Pages